Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Diginex Limited: Diginex Is Powering Enforcement Where Compliance Is No Longer Voluntary (Accesswire) +++ DIGINEX Aktie +5,46%

Foren & Soziale Netzwerke zur HIMS & HERS Aktie

 >HIMS & HERS Aktienkurs 
30.49 EUR    +2.8%    (Tradegate)
Ask: 30.4 EUR / 150 Stück
Bid: 30.31 EUR / 150 Stück
Tagesumsatz: 14194 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
HIMS & HERS Aktie über LYNX handeln
>HIMS & HERS Performance
1 Woche: -3,1%
1 Monat: -1,4%
3 Monate: -38,1%
6 Monate: -41,3%
1 Jahr: +20,0%
laufendes Jahr: +21,7%
>HIMS & HERS Aktie
Name:  HIMS & HERS HEALTH INC.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4330001060 / A2QMYY
Symbol/ Ticker:  82W (Frankfurt) / HIMS (NYSE)
Kürzel:  FRA:82W, ETR:82W, 82W:GR, NYSE:HIMS
Index:  -
Webseite:  https://www.hims.com/
Profil:  Hims & Hers Health, Inc. is a telehealth service p..
>Volltext..
Marktkapitalisierung:  6758.72 Mio. EUR
Unternehmenswert:  7175.15 Mio. EUR
Umsatz:  1887.88 Mio. EUR
EBITDA:  148.81 Mio. EUR
Nettogewinn:  114.24 Mio. EUR
Gewinn je Aktie:  0.51 EUR
Schulden:  954.65 Mio. EUR
Liquide Mittel:  295.25 Mio. EUR
Operativer Cashflow:  274.68 Mio. EUR
Bargeldquote:  1.4
Umsatzwachstum:  68.91%
Gewinnwachstum:  25.37%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  7 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.484.433 USD.
Suchwörter:  HIMS & HERS, HIMS AND HERS, HIMS HERS
Letzte Datenerhebung:  20.12.25
>HIMS & HERS Kennzahlen
Aktien/ Unternehmen:
Aktien: 219.27 Mio. St.
Frei handelbar: 94.25%
Rückkaufquote: -0.11%
Mitarbeiter: 1637
Umsatz/Mitarb.: 0.77 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 31.04%
Bewertung:
KGV: 66.17
KGV lG: 76.18
KUV: 3.88
KBV: 14.01
PEG-Ratio: 2.54
EV/EBITDA: 48.22
Rentabilität:
Bruttomarge: 65.4%
Gewinnmarge: 6.05%
Operative Marge: 5.96%
Managementeffizenz:
Gesamtkaprendite: 9.44%
Eigenkaprendite: 26.21%
>HIMS & HERS Peer Group

Es sind 599 Aktien bekannt.
 
09.12.25 - 02:45
HIMS - reversal trade (TradingView)
 
This is a setup on HIMS I'm going to play with the right volume.
23.11.25 - 02:51
HIMS: timing to buy the dip! (TradingView)
 
HIMS: Timing to buy the dip! Wait for more drop, for an optimal plan. US STOCKS- WALL STREET DREAM- LET'S THE MARKET SPEAK!
14.11.25 - 00:27
$HIMS growth is moderating starting 2025 (TradingView)
 
- NYSE:HIMS had explosive growth in 2025 but it will grow only 20% yoy going forward. - Their eps really sucks and will moderate as well. There is no point in giving a multiple more than 30. Fair value : year : 2025 , eps: 0.48 , fair value: 30 x 0.48 =~ $15 year : 2027 , eps: 0.68 , fair value: 30 x 0.68 =~ $21 year : 2028 , eps: 0.88 , fair value: 30 x 0.88 =~ $27
04.11.25 - 15:03
Bank_of_America_Co_: sell Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 27.8048 €
28.10.25 - 15:03
Put sale on HIMS over earnings (TradingView)
 
I like HIMS and OSCR A LOT in this market and environment right now. :) So, getting HIMS at $38 seems like a gift. JUST closed .80 gain on a put sale. So cost basis would be a tad lower than $37 if I get put shares...
23.10.25 - 02:03
HIMS to $76 (TradingView)
 
HIMS is incredibly profitable and also a highly shorted stock (33%). It might tap support here, but if not just below the trend line seems like a nice entry. Good luck!
17.10.25 - 17:15
HIMS put sale (TradingView)
 
THIS HAS BEEN such a fun stock to trade. BIG DOWN DAY. This put sale is before earnings. AMAZING premiums. Puts the cost basis at $44. GORGEOUS
04.10.25 - 19:27
$HIMS growth slowdown ahead (TradingView)
 
- NYSE:HIMS is quite overvalued. There's no moat to a business model. - They got a good branding that's all. There are 10-15 other startups selling the same things under different umbrella. - They even stole NYSE:NVO flagship weight loss drugs. These cheap alternatives will risk lives of people and will open plethora of lawsuits. - Growth is slowing down to low 20s which calls for correction in the multiple. - Anyone paying more than 20x will likely suffer from massive losses within an year timeframe. - Fundamentally, Year | 2025 | 2026 | 2027 | 2028 EPS | 0.57 | 0.79 | 1.05 | 1.40 EPS% | 5.76% | 38.31% | 32.59% | 33.25% Giving benefit of doubt and being generous, 30x multiple as a base case. Fair stock value: Year | 2025 | 2026 | 2027 | 2028 Price | $17 | $23 | $31 | $42 - We should visit the $23-26 range somewhere in 2026
18.09.25 - 20:33
HIMS Long target 73 $ (TradingView)
 
After retesting 3 times a fib fan resistence, i think it will break very strong this time and it will bounce much higher. Then, on weekly timeframe, it seems a nice cup and handle pattern, for this reason i hope it will go higher in medium-long term First target: 73 $ Second target: 90 $ Third target: 100 $
13.09.25 - 21:33
Biggybaer: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 506.0 €
07.09.25 - 02:24
HIMS Setting up AGAIN... (TradingView)
 
NYSE:HIMS - Dip Buy Box Wins Again! Second time bouncing off our $40-45 support. Breaking out of downtrend with a strong bullish candle. Target $67 then $73 ?
06.09.25 - 20:21
HIMS — Metrics-Led Swing Plan (4H/12H) (TradingView)
 
HIMS — Metrics-Led Swing Plan (4H/12H) Your constraints New entry (early momentum): manage risk at 44. “Best safety” entry: 28. Targets: 50 → 54 → 59 → 70 → 85. Investment window: now → July 2026.--- State 1 — What the Metric Table is Saying (and how to act) Liquidity & Participation Float / Vol·Float: ~0.12× currently → drift/early trend regime. Rules: 51” (promote TP2 path). “Price < 44” (momentum plan invalidated). “Vol·Float ≥ 0.2× / 0.3×” (permission to widen targets). “Close < 48.2 VWAP then failure retest” (reduce risk).--- Disclaimer (read me) This is educational and based on what's visible on your screenshots/metrics. Markets change; confirm levels on your chart and adapt sizing to your own risk tolerance. No financial advice. Always use a hard stop and pre-define risk before entry.
05.09.25 - 14:30
HIMS Bouncing Off Ascending Support (TradingView)
 
HIMS is bouncing off an ascending support, as well as the 200day SMA. It has rising volume with MACD crossing above signal line. Entering 48c 19Dec2025
27.08.25 - 19:06
Don't Hold a Bag, HIMS (TradingView)
 
Hello I am the Cafe Trader. Today we're looking again at the hyped HIMS (Hims & Hers Health). This is a wide range, make sure you get good pricing if you add to the long term. Price is currently sitting right above Strong Buyers These buyers are holding, and the shorts may be exhausting having to cover soon. So I have provided a trade idea to finesse this action. . Green Scenario If buyers continue to hold this demand, I expect a push into the Bottom of Supply around 52. That's the first stop, and a strong reaction there would tell us whether Sellers are really active, or buyers are ready to push into the higher supply zones. The more aggressive case would be continuation all the way into the Extreme Supply area closer to 65–68. Long Term Aggressive: 44–45 (Strong Buyers, current zone) Extreme Value: 26 (Extreme Demand — if buyers completely lose control, this is where I'd expect institutions to step in). For now, HIMS looks bullish off this demand, but keep in mind that if we do lose this b
12.08.25 - 17:12
HIMS LONG Swing Entry Plan (TradingView)
 
NYSE:HIMS LONG Swing Entry Plan Entry Zone 1: $46.10 – $46.50 → Open initial position targeting +8% from entry level. Entry Zone 2: $43.00 – $43.20 → If price dips further, average down with a second equal-sized entry. → New target becomes +8% from the average of Entry 1 and Entry 2. AD Zone : $37.80 – $38.50 → If reached, enter with double the initial size to lower the overall cost basis. → Profit target remains +8% from the new average across all three entries. Risk Management: Stop Loss: Risk is capped at 12% below the average entry price (calculated across all executed positions including the Edit Zone). Position Sizing Approach: Entry 1: 1x Entry 2: 1x AD Zone: 2x → Total exposure: 4x → Weighted average determines final TP and SL calculations. ______________________________________ Legal Disclaimer The information provided in this content is intended for educational and informational purposes only and does not constitute financial, investment, or legal advice or recommendations of any kind. T
05.08.25 - 16:12
8/5/25 - $hims - Shouldn't be green. (TradingView)
 
8/5/25 :: VROCKSTAR :: NYSE:HIMS Shouldn't be green. - this is a trading man's game stock at the moment - but fundamentally, as a grow stock in a heady market, you can't be missing here and leaving wide gaps in guidance for hope - so yeah. i think seeing this thing go red to green is, frankly, surprising and makes me wonder how much liquidity needed to be grabbed on both sides of this thing - but i'd also believe we need to find a lower low (in the 40s before i'd consider owning it again). - gl to the bulls. i've only been in your camp - as you can see - on this chart over the last year/year and a half - but no way i'm owning this thing at this valuation. not a short. but a clear "avoid" at best in my book. be safe out there. don't let the blinders allow you to not manage size (e.g. trimming) is my friendly nudge V
04.08.25 - 11:42
$HIMS TA (TradingView)
 
NYSE:HIMS on the Daily Chart still with an ascending triangle - with resistance at $72-$70 - is still being respected with price touching the top trendline, with weakening volume, an evening star which is suggesting trend exhaustion from the rally from the 23rd June, succeeding the 30% drop from the head and shoulders pattern. On the 15m Chart, you can see a bull flag and pennant form which broke down with confluence from MACD and RSI showing downside pressure. forming a bear pennant. However, both indicators are now flashing bullish divergence — price action is printing lower lows, while RSI and MACD are printing higher lows. Premarket has broken above above the pennant, confirming the divergence.
19.07.25 - 03:45
Him Daily chart (TradingView)
 
NYSE:HIMS — daily chart shaping up nicely ? If it breaks above $53.39, next target could be $61.57 ? Clean setup with ascending support — let's see if volume steps in!
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Alt werden ist natürlich kein reines Vergnügen. Aber denken Sie an die einzig mögliche Alternative! - Robert Lembke
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!